These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30402289)

  • 21. The frequency of complications associated with the use of multiple-dose activated charcoal.
    Dorrington CL; Johnson DW; Brant R;
    Ann Emerg Med; 2003 Mar; 41(3):370-7. PubMed ID: 12605204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prehospital gastrointestinal decontamination of toxic ingestions: a missed opportunity.
    Wax PM; Cobaugh DJ
    Am J Emerg Med; 1998 Mar; 16(2):114-6. PubMed ID: 9517681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accidental administration of activated charcoal into the lung: aspiration by proxy.
    Harris CR; Filandrinos D
    Ann Emerg Med; 1993 Sep; 22(9):1470-3. PubMed ID: 8363122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of activated charcoal on phenytoin pharmacokinetics.
    Rowden AM; Spoor JE; Bertino JS
    Ann Emerg Med; 1990 Oct; 19(10):1144-7. PubMed ID: 2221521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective review of the prehospital use of activated charcoal.
    Villarreal J; Kahn CA; Dunford JV; Patel E; Clark RF
    Am J Emerg Med; 2015 Jan; 33(1):56-9. PubMed ID: 25455049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of charcoal hemoperfusion in dogs with acute fluoroacetamide poisoning].
    Gao Y; Chen YL; Deng HY; Zhong F; Li YJ
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):661-4. PubMed ID: 18021555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosage recommendations for activated charcoal-sorbitol treatment.
    Minocha A; Krenzelok EP; Spyker DA
    J Toxicol Clin Toxicol; 1985-1986; 23(7-8):579-87. PubMed ID: 3831381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does prearrival communication from a poison center to an emergency department decrease time to activated charcoal for pediatric poisoning?
    Tuuri RE; Wright JL; He J; McCarter RJ; Ryan LM
    Pediatr Emerg Care; 2011 Nov; 27(11):1045-51. PubMed ID: 22068066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center.
    Levine M; Curry SC; Padilla-Jones A; Ruha AM
    Ann Emerg Med; 2013 Sep; 62(3):252-8. PubMed ID: 23642908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does emergency medical services transport for pediatric ingestion decrease time to activated charcoal?
    Tuuri RE; Ryan LM; He J; McCarter RJ; Wright JL
    Prehosp Emerg Care; 2009; 13(3):295-303. PubMed ID: 19499464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Out-of-hospital administration of activated charcoal by emergency medical services.
    Alaspää AO; Kuisma MJ; Hoppu K; Neuvonen PJ
    Ann Emerg Med; 2005 Feb; 45(2):207-12. PubMed ID: 15671978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sorbitol catharsis does not enhance efficacy of charcoal in a simulated acetaminophen overdose.
    McNamara RM; Aaron CK; Gemborys M; Davidheiser S
    Ann Emerg Med; 1988 Mar; 17(3):243-6. PubMed ID: 3345017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The feasibility of administration of activated charcoal with respect to current practice guidelines in emergency department patients.
    LoVecchio F; Shriki J; Innes K; Bermudez J
    J Med Toxicol; 2007 Sep; 3(3):100-2. PubMed ID: 18072144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood glucose level after infusing an activated charcoal suspension for acute drug poisoning.
    Amigó-Tadín M; Pané-Vila A; Nogué-Xarau S
    Emergencias; 2020 Jun; 32(3):185-187. PubMed ID: 32395926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical care in the emergency department: A physiologic assessment and outcome evaluation.
    Nguyen HB; Rivers EP; Havstad S; Knoblich B; Ressler JA; Muzzin AM; Tomlanovich MC
    Acad Emerg Med; 2000 Dec; 7(12):1354-61. PubMed ID: 11099425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning.
    Brahmi N; Kouraichi N; Thabet H; Amamou M
    Am J Emerg Med; 2006 Jul; 24(4):440-3. PubMed ID: 16787802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prehospital use of activated charcoal: a pilot study.
    Crockett R; Krishel SJ; Manoguerra A; Williams SR; Clark RF
    J Emerg Med; 1996; 14(3):335-8. PubMed ID: 8782030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study of acute poisonings in Finnish hospital patients.
    Lapatto-Reiniluoto O; Kivistö KT; Pohjola-Sintonen S; Luomanmäki K; Neuvonen PJ
    Hum Exp Toxicol; 1998 Jun; 17(6):307-11. PubMed ID: 9688353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of prehospital treatment with activated charcoal: Who could we treat, who should we treat?
    Isbister GK; Dawson AH; Whyte IM
    Emerg Med J; 2003 Jul; 20(4):375-8. PubMed ID: 12835364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.
    J Toxicol Clin Toxicol; 1999; 37(6):731-51. PubMed ID: 10584586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.